Tokyo, Mar 27 (UNI) A second fatality linked to supplements containing red yeast rice, or "beni-koji" manufactured by Japanese drugmaker Kobayashi Pharmaceutical has been confirmed in the wake of health issues arising from the ingredient, according to the country''s health ministry.